Brain cancer diagnosis and therapy with nanoplatforms

Adv Drug Deliv Rev. 2006 Dec 1;58(14):1556-77. doi: 10.1016/j.addr.2006.09.012. Epub 2006 Sep 28.

Abstract

Treatment of brain cancer remains a challenge despite recent improvements in surgery and multimodal adjuvant therapy. Drug therapies of brain cancer have been particularly inefficient, due to the blood-brain barrier and the non-specificity of the potentially toxic drugs. The nanoparticle has emerged as a potential vector for brain delivery, able to overcome the problems of current strategies. Moreover, multi-functionality can be engineered into a single nanoplatform so that it can provide tumor-specific detection, treatment, and follow-up monitoring. Such multitasking is not possible with conventional technologies. This review describes recent advances in nanoparticle-based detection and therapy of brain cancer. The advantages of nanoparticle-based delivery and the types of nanoparticle systems under investigation are described, as well as their applications.

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Blood-Brain Barrier / drug effects*
  • Brain Neoplasms* / diagnosis
  • Brain Neoplasms* / drug therapy
  • Drug Delivery Systems / methods*
  • Humans
  • Magnetic Resonance Imaging
  • Nanomedicine / methods*
  • Nanomedicine / trends
  • Nanoparticles / therapeutic use*
  • Photochemotherapy / methods*
  • Photochemotherapy / trends